| Literature DB >> 32014023 |
Harald Sauer1, Marie Lobenhofer2, Hashim Abdul-Khaliq3.
Abstract
BACKGROUND: As more and more diagnostic and interventional options are becoming available for use in pediatric patients, techniques of procedural sedation analgesia (PSA) are being administered in considerably growing numbers as well. AIMS: The objective of this research effort was to conduct the first countrywide survey on the status quo of sedation analgesia as delivered to children and adolescents in Germany.Entities:
Keywords: Diagnostic procedures; Interventional procedures; Pediatric centers; Sedation analgesia; Survey
Year: 2020 PMID: 32014023 PMCID: PMC6998146 DOI: 10.1186/s13052-020-0783-y
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Fig. 1Graph illustrating how many of the responding centers (n = 138) perform each of the listed 18 diagnostic and/or interventional procedures and how many of the sedations accompanying each procedure are carried out by either pediatricians or anesthesiologists. Due to incomplete replies, any two figures for a pair of bars may not add up to the sum given on the left
Fig. 2Graph considering only the subset of responding centers (n = × × ×) stating that pediatricians (rather than anesthesiologists) were in charge of a specific sedation scenario. Horizontal bars illustrate the standby personnel provided by the centers for each of the 18 diagnostic and/or interventional procedures and the requirements they impose on the qualification of the pediatricians in charge of the sedation
Basic data and organizational structures for sedation analgesia as carried out in pediatric centers across Germany (based on 134 out of 138 responding centers; in the remaining four centers, no sedation analgesia was performed by pediatricians)
| Center-specific levels of care | |
| Primary care | 3.6% |
| General care | 21.7% |
| Focus care | 30.4% |
| Maximum care | 25.4% |
| University departments | 18.1% |
| Settings for sedation analgesia | |
| Pediatric ward | 87% |
| Intensive care unit | 76.8% |
| Operating room | 13% |
| External/other settings | 79% |
| Frequency of sedation analgesia | |
| > 150 per year | 45.8% |
| 100–150 per year | 13.7% |
| 50–100 per year | 24.4% |
| < 50 per year | 16% |
| Organizational structures | |
| Sedation teams present | 40.5% |
| Regular sedation training courses | 32.3% |
| Documentation protocol for sedation | 80.6% |
| Post-sedation clinical examination | 78.4% |
| Settings for the wake-up phase | |
| (General) pediatric ward | 56.5% |
| Intensive care unit | 11.6% |
| Wake-up room | 11.6% |
| No commitment | 20.3% |
| Parameters monitored in the wake-up phase | |
| Pulse oxymetry (mandatorily) | 99.3% |
| ECG (mandatorily) | 55% |
| RR (mandatorily) | 89.9% |
| RR every 5 min: 21.8%; 10 min: 41.1%; > 10 min: 20.2%; beginning and end only: 16.9% | |
Equipment of the sedation environments used by the responding pediatric centers (n = 134)
| On-location items | Always present | Available if required | Not available | Essentiala |
|---|---|---|---|---|
| Oxygen | 94.2% | 2.2% | 0% | yes |
| Compressed air | 80.4% | 10.1% | 3.6% | yes |
| Suction | 84.1% | 10.1% | 0.7% | yes |
| Electrocardiography | 76.1% | 18.1% | 0.7% | yes |
| Blood pressure (RR) | 73.2% | 20.4% | 0,7% | yes |
| Pulse oxymetry | 94.2% | 2.2% | 0% | yes |
| Capnometry | 5.8% | 43.5% | 31.2% | no |
| Emergencyb | 84.1% | 11.6% | 0% | yes |
| Defibrillator | 26.1% | 59.4% | 7.2% | no |
| Ventilator | 17.4% | 65.9% | 10.1% | no |
Note that MRI environments are not included in this overview
aEssential equipment (modified in accordance with 7, 8)
bEmergency care equipment, including intubation instruments
Popularity of agents used for sedation analgesia in pediatric centers across Germany (n = 134)
| Agents | Centers |
|---|---|
| Midazolam | 97.8% |
| Ketamineb | 86.2% |
| Propofol | 84.8% |
| Fentanyl | 42.0% |
| Chloral hydrate | 32.6% |
| Piritramide | 31.1% |
| Morphine | 29.7% |
| Diazepam | 21.7% |
| Phenobarbital | 21.0% |
| Livopan® | 18.8% |
| Remifentanil | 16.7% |
| Etomidate | 12.3% |
| 4-hydroxybutanoic acida | 10.9% |
| Pethidine | 6.5% |
| Alfentanil | 4.3% |
| Promethazine | 4.3% |
| Other benzodiazepines | 4.3% |
| Sufentanil | 3.6% |
| Thiopental | 2.9% |
| Other opioids | 2.9% |
| Haloperidol | 1.4% |
| Melatonin | 1.4% |
| Dexmedetomidine | 0.7% |
| Chlorprothixene | 0.7% |
| Other: | 8.7% |
a4-hydroxybutanoic acid/γ-hydroxybutyrate
bKetamine/esketamine